BLFS - BioLife Solutions, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
24,531
19,742
11,022
8,227
6,449
Cost of Revenue
7,400
6,217
4,275
3,448
2,635
Gross Profit
17,131
13,525
6,746
4,779
3,814
Operating Expenses
Research Development
2,735
1,298
1,193
2,028
1,379
Selling General and Administrative
12,002
8,565
6,609
7,602
7,453
Total Operating Expenses
14,737
9,863
7,802
9,630
8,831
Operating Income or Loss
2,394
3,662
-1,056
-4,852
-5,017
Interest Expense
6
5
190
100
-
Total Other Income/Expenses Net
8,509
-672
-1,005
-2,787
22
Income Before Tax
11,474
3,266
-2,515
-8,041
-4,995
Income Tax Expense
-
0
-
-
-
Income from Continuing Operations
11,474
3,266
-2,515
-8,041
-4,995
Net Income
11,474
3,266
-2,515
-6,875
-4,214
Net Income available to common shareholders
11,414
2,927
-2,728
-6,875
-4,214
Reported EPS
Basic
-
0.18
-0.21
-0.54
-0.35
Diluted
-
0.14
-0.21
-0.54
-0.35
Weighted average shares outstanding
Basic
-
16,256
13,264
12,643
12,177
Diluted
-
21,627
13,264
12,643
12,177
EBITDA
-
3,609
-1,986
-7,573
-4,674